低剂量照射在肿瘤治疗中的应用研究进展

张海兵 章龙珍

引用本文:
Citation:

低剂量照射在肿瘤治疗中的应用研究进展

    通讯作者: 章龙珍, jsxzzlz@126.com
  • 基金项目:

    国家自然科学基金资助项目(30770916)

Advance of treatment in tumor by low-dose radiation

    Corresponding author: ZHANG Long-zhen, jsxzzlz@126.com
  • 摘要: 电离辐射生物效应与辐射剂量和剂量率有关,大、中剂量照射以损伤效应为主,低剂量照射可诱导机体的兴奋效应、适应性反应、超敏感性、旁效应等。低剂量全身照射通过诱导免疫增强效应、超敏感性、激活抗氧化酶系统及肿瘤细胞凋亡等机制具有抗肿瘤作用,降低随后较大剂量辐射诱发的肿瘤发生率。目前。低剂量照射在肿瘤防治中的应用正成为研究的热点。
  • [1] Keall PJ,lammering G,Lin PS,et al.Tumor control probability predictions for genetic radiotherapy[J].Int J Radial Oncol Biol Phys,2003,57(1):255-263.
    [2] Teh BS,Aquilar-Cordova E,Vlaehaki MT,et al.Combining radiotherapy with gene therapy (from the bench to the bedside):A novel treatment strategy for prostate cancer[J].Oncologist,2002,7(5):458-466.
    [3] Jain PT,Gewirtz DA.Sustmned enhancement of liposome-mediated gene deliver and gene expression in human breast tumor cells by ionizing radiation[J].Int J Radiat Biol,1999,75(2):217-223.
    [4] Gannett CT,Palena C,Chakraborty M,et al.Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphoeytes[J].Cancer Res,2004,64(21): 7985-7994.
    [5] Liao YP,Wang CC,Butterfield LH,et al.Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells[J].J Immunol,2004,173(4):2462-2469.
    [6] Tsai CH,Hang JH,Hsieh KF,et al.Tetracycline-regulated intratumoral expression of interleukin-3 enhances the efficacy of radiation therapy for murine prostate cancer[J].Cancer Gene Therapy,2006,13(12):1082-1092.
    [7] Fujita T,Timme TL,Tabata K,et al.Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinieal model of metastatic prostate canecr[J]. Gene Therapy,2007,14(3):227-236.
    [8] Gupta VK,Park JO,Jaskowiak NT,et al.Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma[J].Ann Surg Oncol,2002,9(5):500-504.
    [9] 唐瑶云,赵素萍,徐婧,等.FCU/5-氟胞嘧啶自杀基因前体药物系统联合放射治疗鼻咽癌的实验研究[J].中华病理学杂志, 2006,35(8):483-487.
    [10] Chen JK,Hu LJ,Wang D,et al.Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro[J].Int J Radiat Oncol Biol Phys,2007,67(5):1538-1547.
    [11] 陈道桢,刘璐,唐秋莎,等.HSV-TK/GCV自杀基因系统联合γ射线治疗宫颈癌的实验研究[J].中华放射医学与防护杂志, 2006,26(1):39-42.
    [12] 陈传本,潘建基,徐鹭英.重组人p53腺病毒注射液结合放射治疗鼻咽癌Ⅱ期临床试验观察[J].中华医学杂志,2003,83(23): 2033-2035.
    [13] 张珊文,肖绍文,刘长清,等.头颈鳞癌基因治疗结合放射治疗的临床研究[J].中华肿瘤杂志.2005,27(7):426-428.
    [14] Agerbaek M,Alsner J,Marcussen N,et al.Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer[J].Br J Cancer, 2003,89(2):298-304.
    [15] Bowen C,Birrer M,Gelmann EP.Retinoblastoma protein-mediated apoptosis after gamma-irradiation[J].J Biol Chem,2002,277(47): 44969-44979.
    [16] Li D,Day KV.Yu S,et al.The role of adenovirus mediateel retinoblastoma 94 in the treatment of head and neck cancer[J]. Cancer Res,2002,62(16):4637-4644.
    [17] Zhang X,Muhani AS,Zhou JH,et al.Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion,chromosomal crisis,and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells[J].Cancer Res,2003,63(4):760-765.
    [18] Roig JM,Molina MA,Cascante A,et al.Adenovirus-mediated retinoblastoma 94 gene transfer induces human pancreatic tumor regression in a mouse xenograft model[J].Clin Cancer Res, 2004,l0(4):1454-1462.
    [19] 赵艳芝,王芹,李进,等.人Rb94基因联合γ-辐射抑制乳腺癌细胞生长的研究[J].中圉辐射卫生,2007,16(3):277-279.
    [20] 俞伟,马林,戴相昆,等.EGFR反义重组腺病莓联合放射线照射乳腺癌的初步实验研究[J].中华放射肿瘤学杂志,2007,16(2):136-139.
    [21] 李彦和,浦佩玉,徐德生,等.表皮牛长因子受钵反义RNA联合γ-刀治疗大鼠C6胶质瘤的实验研究[J].中华神经医学杂志,2007,6(1):13-17.
    [22] Kubota H,Suzuki T,Lu J.Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays im cervical cancer cell lines[J].Int J Radiat Biol,2005,8l (9):701-709.
    [23] Shi W,Teschendorf C,Muzyezka N.et al.Gene therapy delivery of endostatin enhances the treatment efficacy of radiation[J]. RadiutherOneol,2003,66(1):1-9.
    [24] Zheng AQ,Song XR,Yu JM,et al.Liposome transfeeted to plaamid-encoding endostatin gene combined with radiothermpy inhibits liver cancer growth in nude mice[J].World J Gastroetnterol,2005,ll (28):4439-4442.
    [25] Southgate TD,Sheard V,Milsom MD,et al.Radioproteetive gene therapy through retmviral expression of mangalnese superoxide dismutase[J].J Cene Med,2006,8(5):557-565.
  • [1] 杨学琴刘芬菊 . 血小板衍生生长因子及其受体与肿瘤细胞的辐射抗性. 国际放射医学核医学杂志, 2008, 32(4): 240-243.
    [2] 任庆余张延华孟庆乐吴兴 . DTC清甲治疗后诊断性131I SPECT/CT全身显像中的辐射剂量分析. 国际放射医学核医学杂志, 2023, 47(12): 733-737. doi: 10.3760/cma.j.cn121381-202303007-00373
    [3] 朱光旭王小华 . 肿瘤辐射敏感性与细胞凋亡. 国际放射医学核医学杂志, 2000, 24(2): 78-82.
    [4] 李智华李迎新 . 全身照射的剂量学方法. 国际放射医学核医学杂志, 2002, 26(1): 35-37.
    [5] 袁海娟林主戈吴春兴陈宇导周英伟张峰程木华131I治疗分化型甲状腺癌患者体内残留辐射剂量及病房辐射剂量的监测分析. 国际放射医学核医学杂志, 2019, 43(5): 400-404. doi: 10.3760/cma.j.issn.1673-4114.2019.05.003
    [6] 李超李莉许昌韶周菊英徐晓婷俞志英 . 脑胶质瘤SHG-44细胞株照射后子代辐射敏感性. 国际放射医学核医学杂志, 2008, 32(4): 236-239.
    [7] 金问森金一尊 . 整合素介导的细胞信号转导与肿瘤辐射敏感性. 国际放射医学核医学杂志, 2006, 30(4): 237-239.
    [8] 贾晓刚刘强 . 心脏介入诊疗患者辐射剂量和早期外周血细胞变化观察. 国际放射医学核医学杂志, 2009, 33(1): 52-53. doi: 10.3760/cma.j.issn.1673-4114.2009.01.052
    [9] 郭艳婷张鹏飞刘强 . Smac与肿瘤放射治疗. 国际放射医学核医学杂志, 2013, 37(5): 309-313. doi: 10.3760/cma.j.issn.1673-4114.2013.05.014
    [10] 王丽平梁克 . 细胞凋亡与辐射敏感性. 国际放射医学核医学杂志, 2000, 24(2): 75-78.
    [11] 刘光伟龚守良 . 细胞凋亡的线粒体调控机制与电离辐射. 国际放射医学核医学杂志, 2003, 27(2): 90-93.
  • 加载中
计量
  • 文章访问数:  1400
  • HTML全文浏览量:  103
  • PDF下载量:  2
出版历程
  • 收稿日期:  2008-03-02

低剂量照射在肿瘤治疗中的应用研究进展

    通讯作者: 章龙珍, jsxzzlz@126.com
  • 1. 313000 湖州, 浙江省湖州市中心医院放疗科;
  • 2. 221002 徐州, 徐州医学院附属医院放疗科
基金项目:  国家自然科学基金资助项目(30770916)

摘要: 电离辐射生物效应与辐射剂量和剂量率有关,大、中剂量照射以损伤效应为主,低剂量照射可诱导机体的兴奋效应、适应性反应、超敏感性、旁效应等。低剂量全身照射通过诱导免疫增强效应、超敏感性、激活抗氧化酶系统及肿瘤细胞凋亡等机制具有抗肿瘤作用,降低随后较大剂量辐射诱发的肿瘤发生率。目前。低剂量照射在肿瘤防治中的应用正成为研究的热点。

English Abstract

参考文献 (25)

目录

    /

    返回文章
    返回